Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Adenocarcinomas

NCT04669951 is registered in ClinicalTrials.gov with Michael Patrick Achiam as lead sponsor.

NCT NCT04669951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Adenocarcinomas
Lead sponsor
Michael Patrick Achiam
Phase
Not applicable
Overall status
Completed
Start date
November 18, 2019
Completion date
November 30, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus cancer, adenocarcinoma